A year after it reported a Phase 2/3 success, Compass Therapeutics on Monday revealed further results for its closely watched bispecific antibody in second-line biliary tract...
George Church’s Rejuvenate Bio is turning to social networks to help fund its work on one-time gene therapies targeting chronic diseases and root causes of aging.
Intellia Therapeutics said Monday that a single dose of its gene editing treatment dramatically reduced swelling attacks in patients with a rare genetic disorder in a...
Veradermics has succeeded in its first major test as a newly-minted public company. The biotech’s form of oral Rogaine cleared the bar in a Phase 2/3...
After striking a Most Favored Nation deal with the White House in January, Johnson & Johnson will now offer Xarelto at 68% off on TrumpRx, dropping...
Wake up. Brush your teeth. Wash your face. And put on your lifesaving baseball hat. That’s right. If you have treatment-resistant depression, this could be the...
Data from a new study in Nature Neuroscience shows that the brain may be more mechanically connected to the body than previously appreciated. Using mice and computational...
In April 2020, people around the globe were struggling to come to grips with the strictures of unprecedented societal shutdowns aimed at slowing the spread of...
Indian drug giant Sun Pharma has lined up an $11.75 billion acquisition of Organon, a women’s health and biosimilar maker spun out of Merck in 2021....
Turn health data into impact: Browns University's online master in biostatistics & health data science